Bioprinting Applications

Bioprinting involves the use of 3D printing technology to build tissues and organs.

Credit: Hakat/

The first step of bioprinting is to create a model of the organ using biopsy samples, CT scan, and MRI. Then, a mixture of cell and nutrients (also called as bioink) are added to the scaffold in a layer-by-layer approach to generate tissue-like structures.

Bioprinting precisely places cells, proteins, DNA, drug particles, growth factors and biologically active particles spatially to guide tissue generation and formation. It has been applied to several fields of study, including tissue engineering and regenerative medicine, transplantation and clinics, drug screening and high-throughput assays, and cancer research.

Tissue engineering and regenerative medicine

Bioprinting of functional organs is a challenging task as it requires connection to vascular network of arteries, veins, and capillaries; incorporation of various cell types to form complex tissue architecture; mechanical and structural integrity.

Despite these constraints, several tissues which are thin or hollow such as blood vessels and tissues that do not require vasculature such as cartilage have been successfully bioprinted. To generate bioprinted heart tissue, tissue spheroids of human vascular endothelial cells (HUVECs) and cardiac cells were generated.

After bioprinting, tissue spheroids were fused to form a single synchronously beating cardiac tissue patch. However, further efforts are required to tissue engineer such a structurally and functionally complicated organ. Tissue engineering of cartilage tissue requires precise spatial and temporal deposition of cells and biomaterials with sophisticated patterns.

Although great progress has been made to bioprint stratified articular cartilage tissues using stem-cell differentiated chondrocytes, creating cartilages with different structural, biomechanical and biological properties is still a challenge and work in progress.

Another important area in the field of tissue engineering is creating heart valves, as they do not possess regeneration capability and need to be replaced by mechanical or biological prosthetic counterparts if damaged. Studies have shown that anatomically accurate axisymmetric aortic valve geometries can be bioprinted.

Similar studies have been undertaken in liver, lung, pancreas, brain, and skin tissues. In several cases, engineered tissue organoids have been generated; however, further research is required to create a mechanically stable and vascularly connected three-dimensional structure.

Bioprinting for tissue transplantation

Several bioprinted tissue types, including nerve, cardiac, blood vessel, bone and skin, have been transplanted into animals to study their functionality within a host. Such studies have not been performed in humans yet due to lack of FDA approvals.

However, 3D-printed plastic, ceramic or metallic implants for bone tissue replacement have been successfully performed. No adverse effects were observed after the surgery. The challenges to transplant bioprinted tissue and organs involve replicating the vasculature and metabolic state of the organ.

One of the alternatives to this problem could be in situ bioprinting of tissue and organ constructs directly into the defect sites rather bioprinting entire tissue outside, maturating and testing them in vitro before transplanting.  Bioprinting the tissue in situ can lead to recruitment of endothelial cells and incorporation in to the host vasculature.

Pharmaceutical and high throughput screening

Drug discovery involves testing large number of candidate molecules which requires a huge investment of money and human resources. 3D bioprinted tissue models can assist in testing the efficacy of the candidate drugs as they closely mimic the native tissue and can be created in a high-throughput manner by fabrication in microarrays.

Bioprinted tissues can be controlled for their size and microarchitecture, high-throughput capability, co-culture ability, and possesses low-risk of cross-contamination. For example, bioprinted liver micro-organ model has been used to test drug metabolism.

Bioprinting cancer research

The main drawback of two-dimensional tumor models is that they do not represent physiologically relevant environment as they lack three-dimensional interactions with neighboring cells and substrates. Thus, bioprinting offers a mode to understand cellular interactions in three-dimensions to make clinically relevant observations on cancer pathogenesis and metastasis.

For example, human ovarian cancer (OVCAR-5) cells and MRC-5 fibroblasts were bioprinted using an inkjet-based bioprinting platform. Additionally, scaffold-free bioprinting of a breast cancer model has been shown where cancer cells are surrounded by a physiologically relevant stromal milieu comprising MSC-differentiated adipose cells, mammary fibroblasts, and endothelial cells.

These tissues were viable for 2 weeks in vitro with clear compartmentalization of different tissue types. This model was then used to study the effect of different chemotherapy drugs, including tamoxifen.

Further Reading

Last Updated: Feb 26, 2019

Dr. Surat P

Written by

Dr. Surat P

Dr. Surat graduated with a Ph.D. in Cell Biology and Mechanobiology from the Tata Institute of Fundamental Research (Mumbai, India) in 2016. Prior to her Ph.D., Surat studied for a Bachelor of Science (B.Sc.) degree in Zoology, during which she was the recipient of an Indian Academy of Sciences Summer Fellowship to study the proteins involved in AIDs. She produces feature articles on a wide range of topics, such as medical ethics, data manipulation, pseudoscience and superstition, education, and human evolution. She is passionate about science communication and writes articles covering all areas of the life sciences.  


Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    P, Surat. (2019, February 26). Bioprinting Applications. News-Medical. Retrieved on June 20, 2024 from

  • MLA

    P, Surat. "Bioprinting Applications". News-Medical. 20 June 2024. <>.

  • Chicago

    P, Surat. "Bioprinting Applications". News-Medical. (accessed June 20, 2024).

  • Harvard

    P, Surat. 2019. Bioprinting Applications. News-Medical, viewed 20 June 2024,


The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Researchers create new method for better 3D modeling of complex cancers